Monsieur Yannis PREAU / PhD student

médecin spécialiste clinicien et coordination de projets cliniques collaboratifs autour du DT1 et de la nutrition personnalisée

Contact details

Professional experience

Field of activity : Médecine spécialisée

Contract type : Entreprises

Function : Médecin en endocrinologie, diabétologie, maladies métaboliques

Sector : Santé et action sociale

Organization or company : ORPEA-CLINEA France

Company size : 2000

City : Marseille

Country : FRANCE

Jobs

Research : NON

PhD

Title : Biologie-Santé - Spécialité Pathologie Vasculaire et Nutrition

First registration date : 1 October 2019 / 3A

Doctoral school : Recherches Biomédicales

Subject : Rôle du mode de délivrance de l'insuline (Boucle Ouverte vs Pancréas Artificiel) sur le contrôle glycémique et les statuts inflammatoire et oxydant via l'index biologique oméga 3 et le profil alimentaire chez le patient diabétique de type 1

Thesis supervisor : RACCAH Denis

Thesis co-supervisor : ARMAND Martine

Research unit : CRMBM - Centre de Résonance Magnétique Biologique et Médicale

Team : CRMBM - E1 - SYSTEME CARDIOVASCULAIRE

Master's degree

Title : Biologie Santé

November 2019 - Aix-Marseille Université

Publications

  • Retrospective real-life study on the improvement of glucose control over 6 months after switching from an open to a closed-loop in type 1 diabetic patients
    Diabetes Technol Ther, 2022
    Préau Y, Armand M, Galie S, Tréglia C, Schaepelynck P, Raccah D
    https://doi.org/10.1089/dia.2022.2525.abstracts
  • Benefits of a Switch from Intermittently Scanned Continuous Glucose Monitoring (isCGM) to Real-Time (rt) CGM in Diabetes Type 1 Suboptimal Controlled Patients in Real-Life: A One-Year Prospective Study.
    Sensors (Basel), 2021
    Préau Y, Galie S, Schaepelynck P, Armand M, Raccah D
    DOI: 10.3390/s21186131
  • Insulin resistance estimation score is predictive of improvements in glucose control in type 1 diabetes patients when switching from intermittently scanned to real-time continuous glucose monitoring over 6 months.
    Diabetes and Metabolism, 2021
    Préau Y, Galie S, Schaepelynck P, Raccah D, Armand M
    en attente
  • Is estimated glucose disposal rate a pertinent score predicting the glycemic control benefit of switching from isCGM to rtCGM in type 1 diabetes patients?
    Diabetes Technol Ther, 2021
    Préau Y, Galie S, Schaepelynck P, Armand M, Raccah D
    https://doi.org/10.1089/dia.2021.2525.abstracts
  • Potential benefit of switching from isCGM (freestyle libre) to rtCGM (dexcom G4) on AGP parameters in poorly controlled type 1 diabetes patients over 1-year follow-up.
    Diabetes Technol Ther, 2021
    Préau Y, Armand M, Galie S, Schaepelynck P, Raccah D
    https://doi.org/10.1089/dia.2021.2525.abstracts
  • Reply to Letter by Alexander Seibold on “Impact of switching from intermittently scanned to real-time continuous glucose monitoring systems in a type 1 diabetes patient French cohort: an observational study of clinical practices”
    Diabetes Technol Ther, 2021
    Préau Y, Armand M, Galie S, Schaepelynck P, Raccah D
    https://doi.org/10.1089/dia.2021.0087
  • Impact of switching from intermittently scanned to real-time continuous glucose monitoring systems in a type 1 diabetes patient French cohort: An observational study of clinical practices
    Diabetes Technology & Therapeutics, 2020
    Yannis Preau, Martine Armand, Sébastien Galie, Pauline Schaepelynck, Denis Raccah
    DOI: 10.1089/dia.2020.0515

Languages

Anglais : B2 - Intermédiaire supérieur

Français : C2 - Maternel